Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-PODXL antibody MAI1738 and its use for cancer treatment

Anti-PODXL antibody MAI1738 and its use for cancer treatment

US Patent 11267898 · Granted Mar 8, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-TfR1 antibody MAb11-22.1 conjugates for cancer treatment2024
Anti-TfR1 antibody MAb11-22.1 conjugates for cancer treatment2024
Anti-tryptase antibodies, compositions thereof, and uses thereof2024
Preparation of copper(II)-ammonia complex ion sulfidization activator and sulfid2023
Anti-IL13 antibodies and uses thereof2022
Anti-tryptase antibodies, compositions thereof, and uses thereof2020
Anti-tryptase antibodies, compositions thereof, and uses thereof2020
Anti-IL13 antibodies and uses thereof2017
Anti-IL13 antibodies and uses thereof2015
Anti-IL13 antibodies and uses thereof2014
Anti-IL13 antibodies and uses thereof2014
Anti-IL 13 antibodies and uses thereof2012